Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wing, Austin
KP415P01, NCT05685732: An Efficacy and Safety Study w/ Azstarys® in Children With ADHD	Completed	4	246	US	Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo	Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac	Attention Deficit/Hyperactivity Disorder	05/24	05/24
KP415P02, NCT05721235: A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD	Active, not recruiting	4	123	US	Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)	Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac, Worldwide Clinical Trials	Attention Deficit/Hyperactivity Disorder	07/25	07/25
Polaris-AD, NCT05531526: Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants with Early Alzheimer's Disease	Recruiting	3	1150	Europe, US, RoW	AR1001, Placebo	AriBio Co., Ltd.	Alzheimer Disease	12/25	12/27
NCT05156398 / 2021-005246-15: Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects	Recruiting	3	640	Europe, Canada, Japan, US	Rimegepant, BHV3000, Placebo, Matching Placebo	Pfizer, Biohaven Pharmaceuticals Holding Company Limited	Migraine	04/27	04/27
Lall, Ayesha
KP415P01, NCT05685732: An Efficacy and Safety Study w/ Azstarys® in Children With ADHD	Completed	4	246	US	Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo	Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac	Attention Deficit/Hyperactivity Disorder	05/24	05/24
KP415P02, NCT05721235: A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD	Active, not recruiting	4	123	US	Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)	Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac, Worldwide Clinical Trials	Attention Deficit/Hyperactivity Disorder	07/25	07/25
NCT05169710 / 2021-002126-24: A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.	Terminated	3	83	Europe, Canada, Japan, US	SEP-4199 CR 200 mg, SEP-4199 CR 400 mg, Placebo	Sumitomo Pharma America, Inc., Sunovion Pharmaceuticals Inc.	Depressive Episodes, Bipolar I Depression	10/23	10/23
NCT04451408: A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants	Active, not recruiting	1	224	Japan, US	LY3372993, Placebo	Eli Lilly and Company	Alzheimer Disease, Healthy	11/24	11/24